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Abstract : Gene silencing by RNA interference （RNAi） is widely used for assessing 
gene function.  An important advance in the RNAi eld was the discovery that 
plasmid-based RNAi can substitute for synthetic small interfering RNA in vitro and 
in vivo.  However, constitutive and ubiquitous knockdown of gene expression by 
RNAi in mice can limit the scope of experiments because this process can lead to 
embryonic lethality, or result in compensatory overexpression of other genes such 
that no phenotypic abnormalities occur.  Either way, analyses of the physiological 
roles of the gene of interest in adult mice are not possible.  To overcome these 
limitations, we previously constructed a double-conditional short-hairpin RNA 
（shRNA） expression vector that can regulate shRNA expression in a spatio-
temporal manner with a tetracycline-inducible floxed stuffer sequence selectively 
excised by application of Cre recombinase.  In this study, we aimed to modify this 
vector to create an all-in-one vector that produces double-conditional transgenic 
mice through a single round of gene transfer to fertilized eggs.  We added a 
coding region for nuclear localizing Cre （NCre） recombinase with a multi-cloning 
site for a cell-specific promoter into the double-conditional short-hairpin RNA 
（shRNA） expression vector that we previously constructed.  Using Escherichia coli, 
we conrmed successful construction of the vector.  First, we conrmed isopropyl-
β-D-thiogalactopyranoside-induced expression of NCre recombinase through the 
lac operon as a specific promoter by western blotting.  Second, we confirmed 
functional recombination of the oxed sequence of loxP-like TATA-lox by analysing 
restriction enzyme-digested fragments.  This all-in-one double-conditional shRNA 
expression vector will be useful for reversible in vitro and in vivo knockdown of 
target gene expression, in target cells via promoter-specic expression of NCre, and 
at specic times by tetracycline application.
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Introduction
　Silencing of gene expression by RNA interference （RNAi） has become a widely used tool 
for assessing gene function in a rapid and easy manner1）.  An important advance in the RNAi 
field was the discovery that plasmid-based RNAi, including that which uses short-hairpin RNA 
（shRNA）, can substitute for transient RNAi caused by synthetic small interfering RNA （siRNA） 
both in vitro and in vivo2）.  Several vectors have been designed to direct the constitutive 
synthesis of shRNA.  However, expression of shRNA through polymeraseⅢ promoters such 
as U6 appears to be ubiquitous in all cells and non-regulated.  Production of transgenic mice 
by such expression of shRNA has often resulted in early embryonic death due to inhibition 
of gene expression3）.  However, it can also result in mice that show no abnormalities in their 
general phenotype3）.  The latter occurs because of induction of one or more compensatory genes 
that act as counterparts to the target gene, meaning that whole-body homeostasis is maintained 
during growth and development.  In both cases, an analysis of the roles of the gene of interest 
in adult transgenic mice is not possible.  For such analysis, in vivo knockdown of the target gene 
both within a specific cell （spatio） and at a specific time （temporal） is required4）.  However, 
conventional methods for establishing these genetically modified animals with spatio-temporal 
（double-conditional） gene knockdown involve complicated and time-consuming procedures5）.
　To overcome these limitations of RNAi, we previously constructed a double-conditional 
shRNA expression vector6） from the commercially available pSingle-tTS-shRNA vector 
（Takarabio-Clontech, Inc., Shiga, Japan7）.  This vector consists of two functional units : a 
tetracycline （Tet）-induced shRNA expression unit8） for temporal control, and a recombination 
unit sequence that is floxed by two loxP-like TATA boxes （TATA-lox sequences）9） that can be 
excised by Cre recombinase10） for cell-specific control.  
　In this study, we attempted to improve on this previously generated double-conditional shRNA 
expression vector6） by constructing an all-in-one vector―one that contains all essential components 
within a single vector, by integrating a promoter-specific nuclear localizing Cre （NCre） expression 
unit.  We confirmed the inducible expression of NCre based on regulation of the lac promoter （Plac） 
that can be specifically activated by application of isopropyl-β-D-thiogalactopyranoside （IPTG）11） and 
also the functional recombination between floxed TATA-lox sequences in Escherichia coli.
Materials and methods
Bacterial strains and culture conditions
　E. coli strains DH5α （Nippon Gene Co, Tokyo, Japan） and SHuffle Express （SE） （New England 
Biolabs ［NEB］ Inc., Ipswich, MA, USA） were grown at 37°C on LB agar plates containing 50 µg/ml 
ampicillin and 30°C in 2 ×YT medium containing 50 µg/ml ampicillin, respectively.
Construction of plasmids
　First, plasmids containing NCre and Plac were amplified from pCre-Bos （kindly donated by Dr. 
Satoru Arata, Showa University） and pGEX-3X （GE Healthcare UK Ltd., Buckinghamshire, 
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UK） as templates by PCR, using Phusion DNA polymerase （NEB）.  The primer set for NCre 
with multiple cloning sites （MCS） was :
　・Forward primer 1 （F1）
　　 : 5’- CCA ATGCAT （NsiⅠ）GTTTAAACGTACGTCCGGATGATCA （BclⅠ） TCCACCAT
　　     GCCCAAGAAGAAGAGG -3’
　・Reverse primer 1 （R1）
　　 : 5’- GGG CCTAGG （AvrⅡ）CGTTAATGGCTAATCGCCATCTTCCAGCAGG -3’
　The primer set for Plac was :
　・Forward primer 2 （F2）
　　 : 5’- CCA ATGCAT （NsiⅠ）TAGGCACCCCAGGCTTTACAC -3’
　・Reverse primer 2 （R2）
　　 : 5’- GGA AGATCT （BglⅡ）GTTTCCTGTGTGAAATTGTTATCC -3’
　Underlined sections in the primers are the recognition sites of the restriction enzymes shown 
in parentheses.
　The PCR products amplified from the coding region of NCre were ligated using the DNA ligation 
kit Mighty Mix （Takarabio Inc., Shiga, Japan） into the pSingle-tTS-2lox- shRNA vector after digestion 
with NsiⅠ / AvrⅡ（NEB）.  The ligation mixture was transformed into DH5α competent cells. 
Plasmid DNA from these cells was then purified using the GenElute HP Plasmid Miniprep 
Kit （Sigma-Aldrich, St. Louis, MO, USA）, and this was termed the pSingle-tTS-2lox-MCS-
NCre shRNA vector.  Next, the PCR product of Plac was digested with NsiⅠ/ BglⅡ （NEB）, 
for insertion into the NsiⅠ/ BclⅡ（NEB） site of the MCS for the NCre coding region of the 
pSingle-tTS-2lox-MCS-NCre shRNA vector.  This yielded the pSingle-tTS-2lox-Plac-NCre shRNA 
vector （p2lox-Plac-NCre）, which was transformed into DH5α competent cells.  The inserted 
Plac and / or NCre regions in the p2lox-Plac-NCre plasmid were amplified by PCR.  The Plac＋
NCre region was amplified using the F2＋R1 primers ; the Plac-only region was amplified using 
the F2＋R2 primers, and NCre-only region was amplified using the F1＋R1 primers.  These 
regions were separated by electrophoresis on a 1％ agarose gel.  In addition, the amplified Plac-
NCre region was sequenced by Macrogen Japan Corporation （Tokyo, Japan） to confirm correct 
insertion of the Plac and NCre regions.
SDS-PAGE and western blotting to detect IPTG-induced NCre expression
　To detect NCre expression regulated by IPTG in E. coli, SE cells transformed with the 
p2lox-Plac-NCre plasmid were incubated for 4 hours in 2 ×YT medium with or without IPTG 
（100 µM）.  Total protein extracted from each clone was separated by 10％ SDS-PAGE and 
stained with Coomassie brilliant blue （CBB）.  This gel was then transferred electrophoretically 
to an Immun-Blot PVDF membrane for protein blotting （Bio-Rad, Hercules, CA, USA）, and 
probed with anti-Cre antibody （Sigma-Aldrich） or anti-β-galactosidase （Promega, Madison, 
WI, USA）.  After incubation with the primary antibody, the membrane was incubated with 
peroxidase-labeled antibody against mouse IgG （H＋L） （human serum adsorbed） （Kirkegaard 
& Perry Labs Inc., Gaithersburg, MD, USA）.  ImmunoStar Basic （Wako, Tokyo, Japan） was 
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applied to the membrane following the protocols supplied by the manufacturer, and then the 
luminescence signal was analyzed using the C-DiGit （LI-COR, Lincoln, NE, USA） charge-
coupled device imager.
Restriction fragment analysis to detect the recombination between floxed TATA-lox sequences
　To assess whether the novel vector could functionally regulate floxed TATA-lox sequence 
recombination by IPTG-induced NCre expression, SE clones with the novel vector were 
grown in 2 ×YT medium with or without IPTG for 16 hours at 30°C.  IPTG-induced genetic 
recombination between the TATA-lox sequences was confirmed by digested fragment analysis 
using restriction enzyme PvuⅡ （NEB） and electrophoresis on a 1％ agarose gel.  
Ethics approval
　Experimental protocols were approved by the School of Medicine, Showa University Ethical 
Committee （#1607）.
Results
Construction of IPTG-inducible conditional NCre expression vector with Plac
　The strategic schema that we used for constructing the all-in-one vector having loxP-like 
floxed sequence of TATA-lox is shown in Fig. 1（A）: the overall architecture of novel vector 
map including Plac, （B）: the multi-cloning sites for the cell-specific promoter of NCre, and （C）: 
the loxP-like TATA-lox sequence aligned with the original loxP and the partial sequence of the 
modified U6 promoter （PTightU6） including TATA-box.  
　We confirmed insertion of the Plac and NCre coding regions in the p2lox-Plac-NCre vector by 
PCR amplification of three fragments （Plac＋NCre ［1,877 bp］, Plac only ［803 bp］, and NCre 
only ［1,111bp］）, which were separated using 1％ agarose gel electrophoresis ［Fig. 1（D）］.  The 
faint band at about 1,100bp from the Plac＋NCre sample and the smaller bands from the Plac-
only and NCre-only samples were thought to be artifacts―non-specific PCR product and primer 
dimers, respectively.  We also confirmed, by DNA sequencing, that the vector contained the Plac 
sequence followed by the NCre sequence ［Fig. 1（E）］.
Evaluation of conditional NCre expression through Plac by IPTG
　To evaluate the ability of IPTG-induced expression of NCre in the constructed vector, cellular 
lysates from SE clones were examined （after 4 hours of incubation with or without IPTG） 
by SDS-PAGE and CBB staining.  We did not observe any detectable enhanced CBB stained 
bands at about 38 kDa due to NCre （calculated molecular weight, 39.4 kDa） while the induction 
of endogenous β-galactosidase （116 kDa） by IPTG was observed, which served as an internal 
control of lac operon activation due to the presence of Plac as shown in Fig. 2A.  But we 
could confirm IPTG-induced expression of NCre when using anti-Cre and anti-β-galactosidase 
antibodies, as bands at about 38 kDa for NCre and about 125 kDa for β-galactosidase were 
visible on western blotting as shown in Fig. 2B-1 and Fig. 2B-2, respectively.
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Evaluation of IPTG-induced recombination between two TATA-lox sequences
　To evaluate whether the constructed vector could functionally regulate TATA-lox sequence 
recombination by IPTG-induced NCre expression in SE cells, we incubated cells with the p2lox-Plac-
NCre vector with and without IPTG.  IPTG-treated SE cells resulted in a band at about 4,500 bp 
that appeared to be a result of Cre-mediated genetic recombination, but this band was absent when 
SE cells were not treated with IPTG （two lanes in Fig. 3A labeled before PvuⅡ cut）.  Next, we 
tried to confirm the recombination more precisely by restriction fragment analysis, using PvuⅡ （two 
lanes in Fig. 3A labeled after PvuⅡ cut）.  A fragment of about 4.3 kbp （calculated as 4,291 bp） 
resulted from IPTG-treated SE cells that appeared to be a result of the loss of one of the PvuⅡ sites 
between the two TATA-lox sequences by the IPTG-induced expression of NCre, but this band 
was absent when SE cells were not treated with IPTG, and three fragments of about 7 kbp 
（calculated as 7,000 bp）, 2.3 kbp （calculated as 2,313 bp） and 0.9 kbp （calculated as 932 bp） 
still appeared in both cases.  This result is schematically described in Fig. 3B.  This functional 
recombination occurred in the SE strain of E. coli, but it did not occur in other strains that we 
tested―DH5α, BL21-CodonPlus （DL3）-RP （Agilent Technologies Co., SantaClara, CA, USA）, 
NEB 5-alpha F’-Iq （NEB）, and NEB Stable （NEB） （data not shown）.  
Discussion
　In this study, we constructed an all-in-one of double-conditional shRNA expression vector by 
Fig. 2.  IPTG-induced conditional expression of NCre
（A） Total protein staining with CBB following SDS-PAGE. Two clones were used, thus results are 
duplicated. The arrow indicates the expressed β-galactosidase fragment at about 116 kDa.
（B）  Western immunoblot analyses with anti-Cre antibodies used as the primary antibodies for 
NCre expression （B-1） and anti-β-galactosidase antibodies used as the primary antibodies 
for endogenous β-galactosidase expression （B-2）. The （-） and （＋） indicate use of cells 
that were not induced with IPTG, and those that were induced with IPTG, respectively. 
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adding the NCre expression cassette to the pSingle-tTS-2lox-shRNA vector that we previously 
constructed6）.  To do so, the site-specific promoter integrated ahead of NCre was replaced 
between the Psv40 and the Neomycin-resistant region of the original pSingle-tTS-shRNA vector 
to control the expression of NCre using IPTG in E. coli.  This represents promotor-specific 
control of NCre expression which can regulate NCre expression in a cell-specific manner.  This 
research has created an experimental foundation for producing transgenic mice with this double-
conditional shRNA expression vector―an all-in-one vector.  With this type of vector, only a 
single round of gene transfer into the host cells or fertilized eggs is needed because this novel 
vector contains both the Tet-inducible floxed TATA-lox sequence and the cell-specific Cre 
expression systems.  For this reason, it is not necessary to cross genetically engineered mice 
expressing the NCre recombinase in a cell-specific manner with mice that have been engineered 
to have Tet-inducible shRNA expression in a Cre-mediated floxed manner.  We expect that this 
will enable the generation of genetically engineered mice in a shorter period and with less effort.  
　A problem that may arise by putting all systems in the one vector is that the vector may become 
very long, depending on the size of cell-specific promoter.  We carried out preliminary experiments 
and confirmed that integrating the core region of our all-in-one vector （Fig. 4） is possible with the 
Transposon plus Insulators and Super PiggyBac Transposase systems （Transposagen Inc., Lexington, 
KY, USA）, which have been reported to be capable of mobilizing 100 kb DNA fragments in mouse 
Fig. 3.  IPTG-induced floxed TATA-lox sequence recombination in the p2lox-Plac-NCre vector in SE E. coli cells. 
Fragments before and after cutting with PvuⅡ are shown― ie, the non-cut circular plasmid DNA and the 
PvuⅡ-cut linearized fragments from the plasmid DNA. Fragments before and after cutting with PvuⅡ are 
also shown following 16-hour incubation of cells in the absence （-） and presence （＋） of IPTG.
（A） Agarose gel electrophoresis was used for the restriction fragment analysis. In the last two lanes on the 
right, the black arrow indicates the fragment with IPTG induction at about 4,300 bp. The white arrows 
indicate fragments of about 7,000 bp, 2,300 bp and 900 bp, with and without IPTG induction. M is the 
1 kb ladder DNA size marker.
（B） Schematic representation of IPTG-induced NCre-mediated recombination in the p2lox-Plac-NCre vector. 
The PvuⅡ restriction site is indicated by small black vertical lines. The expected PvuⅡ restriction 
fragment sizes are indicated before （upper） and after （lower） the NCre （☆ and bold arrow）-mediated 
recombination by IPTG application （＋ IPTG）.
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embryonic stem cells12，13）.
　The advantage of this novel system is that it provides a means of reversible knockdown of a 
gene of interest by Tet application at the target life stage in an experiment.  When Plac is replaced 
with a target cell-specific promoter, NCre will express within the target cells, leading to shRNA-
mediated knockdown of the gene of interest in these cells by Tet application （Fig. 4）.  In addition, 
for clinical use, replacing Plac with a tumor-specific promoter and an shRNA sequence that 
targets an anti-apoptotic factor such as Bcl-2 could induce tumor cell-specific apoptosis by Tet 
application14）.  
　In conclusion, the novel vector that we constructed enables spatial and temporal control 
of shRNA expression in vivo to facilitate functional genetic regulation in specific cells.  It 
could also be used for cell targeting, to analyze the functional roles of specific genes and the 
physiological roles of specific cells during precise periods of life.
Conict of interest disclosure
　We have no financial conflict of interest to disclose concerning this study.
Fig. 4.   Schematic representation of in vitro or in vivo application of the all-in-one double-conditional 
shRNA vector 
The core region of the vector （shown in the upper part of the schematic） is integrated into 
the mouse genome. In specific differentiated target cells, promoter-specific expression of NCre 
will excise the stuffer sequence containing the terminator poly T signal sequence between 
the loxP-like TATA-lox sequences. Before Tet application, the modified Tet-inducible promoter 
（PTightU6） is inactivated （arrow with cross） by the transcriptional trans-silencer （tTS）. After Tet 
application, Tet binds to the tTS, which frees the PTightU6 from the tTS, leading to activation of 
the PTightU6 and expression of the shRNA, which causes knockdown of the target gene product 
（shown in the lowest part of the schematic）.
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